Globus Medical Inc - Ordinary Shares - Class A
GMED
Market Cap$5.69B
Close$
$76.32
51.2% upside
Current Fair Value
51.2% upsideUndervalued by 51.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.69 Billion |
|---|---|
| Enterprise Value | $5.58 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $1.07 |
| Beta | 1.05 |
| Outstanding Shares | 112,624,816 |
| Avg 30 Day Volume | 844,347 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 46.27 |
|---|---|
| PEG | -66.13 |
| Price to Sales | 3.88 |
| Price to Book Ratio | 1.44 |
| Enterprise Value to Revenue | 3.56 |
| Enterprise Value to EBIT | 27.67 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
ESG Score
No data
About Globus Medical Inc
CEO: David Demski